Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Privia Health Group Inc (PRVA) PT Raised to $32 at Citi
February 27, 2025 4:33 PM ESTCiti analyst Daniel Grosslight raised the price target on Privia Health Group Inc (NASDAQ: PRVA) to $32.00 (from $26.00) while maintaining a Buy rating.
The analyst comments "PRVA reported solid 4Q results beating guidance/expectations across the board. Practice collections grew ~5% y/y, as... More
